108 related articles for article (PubMed ID: 30543932)
1. Mass spectrometry-based peptidome profiling of human serous ovarian cancer tissues.
Xu J; Wang X; Xu P; Liu S; Teng F; Liu X; Zhu Q; Hua X; Gong Z; Jia X
Int J Biochem Cell Biol; 2019 Feb; 107():53-61. PubMed ID: 30543932
[TBL] [Abstract][Full Text] [Related]
2. Potential Significance of Peptidome in Human Ovarian Cancer for Patients With Ascites.
Huang X; Zhou J; Tang R; Han S; Zhou X
Int J Gynecol Cancer; 2018 Feb; 28(2):355-362. PubMed ID: 29240604
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Secreted Peptidome from Omental Adipose Tissue in High-Grade Serous Ovarian Cancer.
Pan H; Xu S; Dai C; Jia G; Ge L; Xu P; Jia X
Crit Rev Eukaryot Gene Expr; 2023; 33(3):27-38. PubMed ID: 37017667
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.
Ibrahim FF; Jamal R; Syafruddin SE; Ab Mutalib NS; Saidin S; MdZin RR; Hossain Mollah MM; Mokhtar NM
J Ovarian Res; 2015 Aug; 8():56. PubMed ID: 26260454
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.
Longuespée R; Gagnon H; Boyon C; Strupat K; Dauly C; Kerdraon O; Ighodaro A; Desmons A; Dupuis J; Wisztorski M; Vinatier D; Fournier I; Day R; Salzet M
Proteomics Clin Appl; 2013 Jun; 7(5-6):337-54. PubMed ID: 23589350
[TBL] [Abstract][Full Text] [Related]
6. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
8. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
9. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.
Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z
Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma.
Li XQ; Zhang SL; Cai Z; Zhou Y; Ye TM; Chiu JF
Cancer Lett; 2009 Mar; 275(1):109-16. PubMed ID: 19056166
[TBL] [Abstract][Full Text] [Related]
11. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
[TBL] [Abstract][Full Text] [Related]
13. Comparative peptidome profiling reveals critical roles for peptides in the pathology of pancreatic cancer.
Li X; Li J; Zhang B; Gu Y; Li Q; Gu G; Xiong J; Li Y; Yang X; Qian Z
Int J Biochem Cell Biol; 2020 Mar; 120():105687. PubMed ID: 31927104
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.
Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R
Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
16. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
[TBL] [Abstract][Full Text] [Related]
17. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
18. High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer.
Lu J; Wang SL; Wang YC; Wu YN; Yu X; Zhao WZ; Wang JH
Oncotarget; 2017 Jun; 8(25):41189-41201. PubMed ID: 28476025
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA MIR4697HG Promotes Cell Growth and Metastasis in Human Ovarian Cancer.
Zhang LQ; Yang SQ; Wang Y; Fang Q; Chen XJ; Lu HS; Zhao LP
Anal Cell Pathol (Amst); 2017; 2017():8267863. PubMed ID: 28168162
[TBL] [Abstract][Full Text] [Related]
20. Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.
Wei BR; Hoover SB; Ross MM; Zhou W; Meani F; Edwards JB; Spehalski EI; Risinger JI; Alvord WG; Quiñones OA; Belluco C; Martella L; Campagnutta E; Ravaggi A; Dai RM; Goldsmith PK; Woolard KD; Pecorelli S; Liotta LA; Petricoin EF; Simpson RM
PLoS One; 2009 Oct; 4(10):e7670. PubMed ID: 19888321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
